MedImmune

4 results

Malin’s investee company Poseida Therapeutics has filed for a potential IPO.

Life sciences investment company Malin said on Monday that its investee company Poseida Therapeutics has filed for a potential initial public offering(...)

Terry McWade, chief executive of Valitacell. Photograph: Conor McCabe

The breast cancer drug Herceptin and the rheumatoid arthritis drug Humira are breakthrough treatments in their respective areas. Both are also biologi(...)

Valitacell chief executive Dr Terry McWade: co-founded the company with Dr Jerry Clifford.

An Irish start-up has big plans to provide specialised services for the world’s biggest pharmaceutical companies. Its client list so far includes US (...)

Immunocore, which was spun out of Oxford University in 2008, is developing novel T cell receptor (TCR) based therapies with the potential to treat a variety of cancers, viral infections and autoimmune diseases

Malin, the Irish-based company set up by a number of former Elan executives to invest in privately held life science assets, has invested $80 million (...)